tDCS for Post-Stroke Cognitive Impairment

Launched by UNIVERSITY OF OKLAHOMA · Jul 17, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "tDCS for Post-Stroke Cognitive Impairment," is exploring how a type of brain stimulation, called transcranial direct current stimulation (tDCS), can help improve brain function and memory in people who have experienced a stroke and are facing mild cognitive difficulties. The study is currently looking for participants aged 65 to 74 years who have had an ischemic stroke (the most common type of stroke caused by a blockage of blood flow to the brain) at least 10 days but less than 5 months ago and are experiencing some cognitive issues, as measured by a simple test.

If you or a loved one is interested in participating, it's important to note that individuals with certain medical or psychiatric conditions, severe depression, or a history of serious neurological issues may not be eligible. Participants will receive the tDCS treatment, which is non-invasive and painless, and they will be monitored during the study to see how it affects their thinking and memory. This trial aims to gather valuable information that could lead to better care for those living with cognitive challenges after a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) ischemic stroke participants in sub-acute phase (at least 10 days after stroke event or discharge and under 5 months post-event) with cognitive dysfunction (MoCA \<26);
• Exclusion Criteria:
• • 1. clinically significant or unstable medical or psychiatric condition;
• • 2. diagnosis of severe depression;
• • 3. history of relevant neurological diagnosis (e.g., epilepsy);
• • 4. previous neurosurgical procedure with craniectomy;
• • 5. contraindications to tDCS (implanted brain medical devices);
• • 6. severe visual impairment, hearing impairment, aphasia, neglect or dementia.